England – 16/10/2011 – The science of Glycobiology grows in importance
The science of glycobiology is an amalgamation of the disciplines of biochemistry and carbohydrate chemistry. It was first recognized as a separate science in 1988 and since then the importance of glycobiology has grown rapidly.
Glycobiology research has produced many important drugs, such as Heparin, Chondroitin sulfate, Dermatan sulfate, Keratan sulfate, Heparin sulfate and Hyaluronan. They are used to treat many conditions including inflammation, to assist with wound healing, as an anti-coagulant and for osteoporosis.
The future of Glycobiology
Glycobiology studies the way in which sugars and complex carbohydrates work within the body. Complex carbohydrates in particular glycosaminoglycans (GAGS) are involved in every function of the body and play a key role in how the body develops. One of its main roles within the body is to act as a marker for cells. These markers tell each cell what the cells surrounding them are and enables that cell to decide on whether surrounding cells are a threat or if they need to interact with them in some way.
When the balance of complex carbohydrates, in particular glycosaminoglycans, is not right in the body disease develops. Glycobiology seeks to identify each glycosaminoglycan (GAG), what it does in the body, and how it interacts within the body so it is the key to understanding and curing many diseases.
Glycobiology is expected to produce new treatments for Alzheimer’s and cancer. It is also expected to come up with new anti-viral drugs to help in tackling diseases like flu, dengue fever and the many other virally transmitted diseases. It is believed that this relatively new science will produce the first truly broad spectrum anti-viral drugs, in the near future.
Iduron produces the glycosaminoglycans (GAGS) used in for Glycobiology research without their products this valuable research would be impossible. Every sale they make helps The Paterson Institute for Cancer Research, The University of Manchester and Cancer Research UK because they have a profit sharing agreement, This means that Iduron is at the forefront of disease prevention in more ways than one.
Contact:
Iduron Ltd
Wilmslow Road
M20 4BX
Manchester
United Kingdom
Phone: +44 (0)161 446 3205
Phone/fax: +44 (0)161 918 7030
Web: http://www.iduron.co.uk/